Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

INDUSTRY 11OTHER 8NETWORK 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Urinary Bladder Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urethral Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Prostatic Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Cyclophosphamide 39Docetaxel 30Tamoxifen 29Paclitaxel 27Doxorubicin 26Trastuzumab 20Radiotherapy 18Epirubicin 16Letrozole 13exemestane 11Fluorouracil 11Anastrozole 11Capecitabine 10Bevacizumab 10Immunohistochemistry 9Filgrastim 9Fulvestrant 8Methotrexate 7Gene Expression Profiling 7palbociclib 6Zoledronic Acid 6Microarray Analysis 6Lapatinib 6Goserelin 6Chemotherapy, Adjuvant 6Amplified Fragment Length Polymorphism Analysis 6Vinorelbine 5Triptorelin Pamoate 5Carboplatin 5Absorptiometry, Photon 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Breast Neoplasms × Gefitinib × Clear all
NCT00066378 2013-10-24

Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
71 enrolled
Breast

Breast Neoplasms

NCT00066339 2012-07-18

Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
44 enrolled
Breast

Breast Neoplasms

NCT00052169 2007-12-18

Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer

NSABP Foundation Inc

Phase 2 Completed
33 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡